Phase 2 Myocardial Fibrosis Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

HFpEFMyocardial FibrosisLVDD

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation50 enrolled1 locationNCT06655480

Recruiting

Phase 2

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Sickle Cell DiseaseDiffuse Myocardial Fibrosis

Children's Hospital Medical Center, Cincinnati24 enrolled1 locationNCT05012631